29 completed, 6 unknown, 4 recruiting, 3 terminated. 8 Phase 2, 6 Not applicable, 3 Phase 1, 3 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Recruiting 1, Terminated 1, Withdrawn 1 |
| Not applicable | 6 | Completed 3, Recruiting 2, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 3 | Withdrawn 2, Recruiting 1 |
| Phase 4 | 2 | Completed 2 |
Follow Infection Viral: new trials by email Literature Review of Infection Viral trials Research Report on Infection Viral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients Metagenomic plasma-based test for agnostic pathogen detection - Infection, Infections, Bacterial | Not applicable | Recruiting | Karius, Inc. | 2000 | 2025-10-27 | 2026-01-30 |
| Nosocomial Influenza Surveillance of 2022 - 2027 Seasonal Period Influenza-like illness group - Infection Viral | Withdrawn | Hospices Civils de Lyon | 2025-03-09 | 2025-03-11 | ||
| Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts Adult and Pediatrics - Infection, Bacterial, Infection Viral | Completed | Beckman Coulter, Inc. | 650 | 2024-06-12 | 2025-06-05 | |
| Development and Validation of (Bio)Sensors for the Identification of Pathogens Nanobiotechnology platforms - Infections, Infection, Bacterial | Completed | University of Bologna | 149 | 2024-05-30 | 2025-12-10 | |
| Xofluza-Wearables Feasibility-Study Baloxavir Marboxil - Infection, Coronavirus, Infections | Phase 4 | Completed | Children's Hospital of Philadelphia | 498 | 2023-12-14 | 2025-07-11 |
| RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Vapendavir, Placebo - COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection | Phase 2 | Completed | Altesa Biosciences, Inc. | 52 | 2023-11-20 | 2025-09-30 |
| Xanthohumol and Viral Infections (XL) Xanthohumol, Placebo - Infection Viral | Not applicable | Recruiting | University of Vienna | 100 | 2023-08-01 | 2025-04-15 |
| Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults Low dose A/H2N3c + standard dose MF59, Intermediate dose A/H2N3c + standard dose MF59, High dose A/H2N3c + standard dose MF59 - Influenza, Human, Infections | Phase 1 | Completed | Seqirus | 600 | 2023-06-15 | 2026-09-21 |
| Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on Day 22 - Influenza, Human, Infections | Phase 2 | Completed | Seqirus | 480 | 2023-06-07 | 2024-12-13 |
| Medicine-induced Cardiac Hemodialysis on COVID-19 Nifedipine 30 MG, Kangzhu BPCB0A-3A, Low Mobility - Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis | Phase 4 | Completed | Yang I. Pachankis | 1 | 2023-01-02 | 2023-02-03 |
| Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room No intervention - Sepsis, Septic Shock | Recruiting | Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) | 3300 | 2022-10-25 | 2025-10-02 | |
| A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers VB10.2129, VB10.2210 - COVID-19, Infection Viral | Phase 1 / Phase 2 | Completed | Nykode Therapeutics ASA | 68 | 2021-11-01 | 2024-04-11 |
| Micro-hematology Analyzer for Viral/Bacterial Description complete blood count - Infection Viral, Infection, Bacterial | Unknown | RizLab Health, Inc. | 200 | 2021-07-25 | 2021-11-03 | |
| Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19) Longan nasal spray, Placebo - Infection Viral | Not applicable | Unknown | Chulalongkorn University | 60 | 2021-07-01 | 2021-05-17 |
| COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2) Review of medical file, Phone call interview - Infection Viral | Completed | Hospices Civils de Lyon | 87 | 2021-06-22 | 2022-01-04 | |
| Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19) Stabilized hypochlorous acid, Placebo - SARS-CoV Infection, Covid19 | Phase 2 / Phase 3 | Withdrawn | Hospital Universitario San Ignacio | 2021-02-15 | 2023-03-03 | |
| Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19) Respiratory infections - Influenza, SARS (Severe Acute Respiratory Syndrome) | Terminated | Imperial College London | 8 | 2021-01-25 | 2024-05-17 | |
| COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave COVID-19 infection - Covid19, Death | Completed | Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal | 1197 | 2021-01-01 | 2021-07-28 | |
| COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor) Review of medical patient file, Phone call interview - Infection Viral | Completed | Hospices Civils de Lyon | 72 | 2020-12-21 | 2021-04-26 | |
| Exercise Influence on COVID-19 COVID-19 survey - Infection Viral, Exercise | Unknown | University of Salamanca | 30000 | 2020-12-04 | 2020-11-12 |
Showing 20 of 45. Sign in to see all of them.
Virus Diseases (45) · COVID-19 (15) · Coronavirus Infections (12) · Infections (10) · Respiratory Tract Infections (8) · Bacterial Infections (7) · Influenza, Human (6) · RNA Virus Infections (4) · Severe Acute Respiratory Syndrome (4) · Disease (2) · Parasitic Diseases (2) · Pneumonia (2) · Alopecia Areata (1) · Alzheimer Disease (1) · Anemia, Pernicious (1)
Infections (35) · Respiratory Tract Diseases (23) · RNA Virus Infections (22) · Nidovirales Infections (21) · Coronaviridae Infections (20) · Lung Diseases (17) · Respiratory Tract Infections (16) · Pneumonia (15) · Pneumonia, Viral (15) · Coronavirus Infections (9) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Bacterial Infections and Mycoses (7) · Orthomyxoviridae Infections (6) · Disease Attributes (4)
Hydroxychloroquine (2) · Azithromycin (1) · BNT162 Vaccine (1) · Blood Cell Count (1) · COVID-19 Drug Treatment (1) · Capsules (1) · Cold Temperature (1) · Cyclophosphamide (1) · Docosahexaenoic Acids (1) · Duloxetine Hydrochloride (1) · Enalapril (1) · Enoxaparin (1) · Ganciclovir (1) · Lansoprazole (1) · MF59 oil emulsion (1)
Hospices Civils de Lyon (6) · University Hospital, Lille (3) · Centre Hospitalier Universitaire de Nice (2) · Federico II University (2) · Seqirus (2) · Aier School of Ophthalmology, Central South University (1) · Altesa Biosciences, Inc. (1) · Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Beckman Coulter, Inc. (1) · Benha University (1) · BioNTech SE (1) · Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal (1) · Children's Hospital of Philadelphia (1) · Chronic Obstructive Pulmonary Disease Trial Network, Denmark (1)
France (13) · United States (8) · Italy (4) · United Kingdom (3) · Canada (2) · Austria (1) · Brazil (1) · China (1) · Denmark (1) · Egypt (1) · Germany (1) · Netherlands (1) · Norway (1) · Philippines (1) · Turkey (Türkiye) (1)
Andrew McGovern, MD (1) · Andreza A Feitosa Ribeiro, PhD (1) · Anthony Sochet, MD (1) · Catherine S Birken, MD (1) · Christopher Chiu, PhD (1) · David B Peden, MD (1) · David Haan (1) · Delphine Garrigue, MD (1) · Juan Zambrano, MD. M.Sc. (1)
PMID 41093046, PMID 23665863, PMID 30526535, PMID 32359149, PMID 32522282, PMID 32809969, PMID 33081817, PMID 33093033, PMID 33388386, PMID 33502773, PMID 34053788, PMID 34785540, PMID 35157313, PMID 35244208, PMID 35484817, PMID 36125366, PMID 37681818, PMID 38454482, PMID 39197299, PMID 40750284, PMID 40766870